Abstract
Osteoporosis and hemochromatosis are both late-onset preventable diseases, but future genetic tests for these conditions are likely to differ in their predictive abilities. To determine whether interest in a specific genetic test for hemochromatosis would be higher than interest in a theoretical test for osteoporosis susceptibility, undergraduate women at the University of Cincinnati (N = 181) were surveyed regarding their interest in genetic testing for these conditions. The clinical features of the diseases and the limits of a genetic test for each were described. Sixty-three percent of the total population was interested in genetic testing with a trend toward higher interest in the osteoporosis group. Disease familiarity, perceived disease severity, and perceived risk for disease appear to be more important predictors of genetic test acceptance than diagnostic specificity. Suggested implications for the development of population genetic screening tests are discussed.
Similar content being viewed by others
References
Adams PC, Deugnier Y, Moirand R, Brissot P (1997) The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 25:162-166.
Adams PC, Valberg LS (1996) Evolving expression of hereditary hemochromatosis. Semin Liver Dis 16:47-54.
Ailinger RL, Emerson J (1998) Women's knowledge of osteoporosis. Appl Nurs Res 11:111-114.
Ailinger RL, Harper DC, Lasus HA (1998) Bone up on osteoporosis. Development of the facts on osteoporosis quiz. Orthop Nurs 17:66-73.
Ajzen I, Fishbein M (1980) Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall.
Allen K, Williamson R (1999) Should we genetically test everyone for haemochromatosis? J Med Ethics 25:209-214.
Andrykowski MA, Lightner R, Studts JL, Munn RK (1997) Hereditary cancer risk notification and testing: How interested is the general population? J Clin Oncol 15:2139-2148.
Andrykowski MA, Munn RK, Studts JL (1996) Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 25:527-536.
Bandura A (1977) Self-efficacy: Toward a unifying theory of behavioral change. Psychol Rev 84:191-215.
Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV, and the Hemochromatosis Management Working Group. (The Working Group is comprised of Cocchiarella L, Dooley JS, Fellitti V, Brandhagen D, Herbert V, and Krikker MA.) (1998) Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 129:932-939.
Bilezikian JP (1996) Current and future nonhormonal approaches to the treatment of osteoporosis. Int J Fertil Menopausal Stud 41:148-155.
Bothwell TH, Charlton RW, Motulsky AG (1995) Hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, pp 2237-2259.
Bouillon R, Burckhardt P, Christiansen C, Fleisch HA, Fujita T, Gennari C, Martin TJ, Mazzuoli G, Melton LJ, Ringe JD, Riis P, Peck WA, Samisioe G, Shulman LE (1991) Consensus development conference: Prophylaxis and treatment of osteoporosis. Am J Med 90:107-110.
Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J (1999) Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 55:419-430.
Cartwright GE, Edwards CQ, Kravitz K, Skolnick M, Amos DB, Johnson A, Buskjaer L (1979) Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med 301:175-179.
Center for Disease Control (2001) Youth Risk Behavior Survey (Online). Oct 17, 2000.
Christian JC, Yu PL, Slemenda CW, Johnston CC, Jr (1989) Heritability of bone mass: A longitudinal study in aging male twins. Am J Hum Genet 44:429-433.
Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G (1998) Iron overload, public health, and genetics: Evaluating the evidence for hemochromatosis screening. Ann Intern Med 129:971-979.
Cohn SH, Abesamis C, Yasumura S, Aloia JF, Zanzi I, Ellis KJ (1977) Comparative skeletal mass and radial bone mineral content in black and white women. Metabolism. 26:171-178.
Consortium TUH, Worwood M, (1997) A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 41:841-844.
Craufurd D, Dodge A, Kerzin-Storrar L, Harris R (1989) Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 2:603-605.
Croyle RT, Dutson DS, Tran VT, Sun YC (1995) Need for certainty and interest in genetic testing. Womens Health 1:329-339.
Croyle RT, Lerman C (1993) Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 22:284-292.
Davis JG (1998) Population screening for hemochromatosis: The evolving role of genetic analysis. Ann Intern Med 129:905-908.
Dequeker J, Nijs J, Verstraeten A, Geusens P, Gevers G (1987) Genetic determinants of bone mineral content at the spine and radius: A twin study. Bone 8:207-209.
Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8:369-375.
Eisman JA (1999) Genetics of osteoporosis. Endocr Rev 20:788-804.
Feder JN (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408.
Fishbein M, Middlestadt SE. (1989) Using the Theory of Reasoned Action as a framework for understanding and changing AIDS-related behaviors. In VM Mays, GW Albee, and SF Schneider (eds) Primary Prevention of AIDS: Psychological Approaches. Newbury Park, CA: Sage, pp 93-110.
Friedman LC, Webb JA, Bruce S, Weinberg AD, Cooper HP (1995) Skin cancer prevention and early detection intentions and behavior. Am J Prev Med 11:59-65.
Giguere Y, Rousseau F (2000) The genetics of osteoporosis: Complexities and difficulties. Clin Genet 57:161-169.
Graham ID, Logan DM, Hughes-Benzie R, Evans WK, Perras H, McAuley LM, Laupacis A, Stern H (1998) How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey. Cancer Prev Control 2:167-172.
Heaney RP (1993) Bone mass, nutrition, and other lifestyle factors. Am J Med 95:29S-33S.
Kahneman D, Tversky A (1982) The psychology of preference. Sci Am 246:160-171
Keen RW, Kelly PJ (1997) Genetic factors in osteoporosis: What are the implications for prevention and treatment? Drugs Aging 11:333-337.
Kessler S, Field T, Worth L, Mosbarger H (1987) Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 26:259-270.
Kim KK, Horan ML, Gendler P, Patel MK (1991) Development and evaluation of the Osteoporosis Health Belief Scale. Res Nurs Health 14:155-163.
Lendon CL, Ashall F, Goate AM (1997) Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277:825-831.
Leslie M, St Pierre RW (1999) Osteoporosis: implications for risk reduction in the college setting. J Am Coll Health 48:67-71.
Liau A, Zimet GD (2000) Undergraduates' perception of HIV immunization: Attitudes and behaviours as determining factors. Int J STD AIDS 11:445-450.
Liau A, Zimet GD, Fortenberry JD (1998) Attitudes about human immunodeficiency virus immunization: The influence of health beliefs and vaccine characteristics. Sex Transm Dis 25:76-81.
Mastromauro C, Myers RH, Berkman B (1987) Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 26:271-282.
Meissen GJ, Berchek RL (1987) Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet 26:283-293.
Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275-278.
Motulsky AG, Beutler E (2000) Population screening in hereditary hemochromatosis. Annu Rev Public Health 21:65-79.
Nguyen TV, Blangero J, Eisman JA (2000) Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res 15:392-401.
Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107-1119.
NIH (2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement Online 2000 Mar 27–29; 17(1):1-36.
Obermayer-Pietsch B, Chararas C, Kotschan S, Walter D, Leb G (2000) Genetic background of osteoporosis. Acta Med Austriaca 27:18-22.
O'Connor BV, Cappelli M (1999) Health beliefs and the intent to use predictive genetic testing for cystic fibrosis carrier status. Psychol, Health Med 4:157-168.
Palmer CGS, Sainfort F (1993) Toward a new conceptualization and operationalization of risk perception within the genetic counseling domain. J Genet Counsel 2:275-295.
Peck WA, Riggs BL, Bell NH, Wallace RB, Johnston CC, Jr, Gordon SL, Shulman LE (1988) Research directions in osteoporosis. Am J Med 84:275-282.
Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S (1987) Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706-710.
Press NA, Yasui Y, Reynolds S, Durfy SJ, Burke W (2001) Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am J Med Genet 99:99-110.
Roberts JS (2000) Anticipating response to predictive genetic testing for Alzheimer's disease: A survey of first-degree relatives. Gerontologist 40:43-52.
Rosenstock IM (1974) The Health Belief Model and preventive health behavior. Health Educ Monogr 2:354-386.
Senior V, Marteau TM, Weinman J (2000) Impact of genetic testing on causal models of heart disease and arthritis: An analogue study. Psychol Health 14:1077-1088.
Shiloh S, Ben-Sinai R, Keinan G (1999) Effects of controllability, predictability, and information-seeking style on interest in predictive genetic testing. Personality Soc Psychol Bull 25:1187-1195.
Shiloh S, Sagi M (1989) Effect of framing on the perception of genetic recurrence risks. Am J Med Genet 33:130-135.
Simon M, Bourel M, Genetet B, Fauchet R (1977) Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 297:1017-1021.
Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC, Jr (1991) Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 6:561-567.
Smith KR, Croyle RT (1995) Attitudes toward genetic testing for colon cancer risk. Am J Public Health 85:1435-1438.
Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC, Jr (1973) Genetic factors in determining bone mass. J Clin Invest 52:2800-2808.
Tambor ES, Rimer BK, Strigo TS (1997) Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population. Am J Med Genet 68:43-49.
Tversky A, Kahneman D (1974) Judgment under uncertainty: Heuristics and biases. Science 185:1124-1131.
Wertz DC, Janes SR, Rosenfield JM, Erbe RW (1992) Attitudes toward the prenatal diagnosis of cystic fibrosis: Factors in decision making among affected families. Am J Hum Genet 50:1077-1085.
Wertz DC, Sorenson JR, Heeren TC (1986) Clients' interpretation of risks provided in genetic counseling. Am J Hum Genet 39:253-264.
Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA (1996) Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 245:139-200.
Wolff I, van Croonenborg JJ, Kemper HC, Kostense PJ, Twisk JW (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre-and postmenopausal women. Osteoporos Int 9:1-12.
Worwood M (2000) Early detection of genetic hemochromatosis: Should all young adults be offered the genetic test? Genet Test 4:219-228.
Zimet GD, Fortenberry JD, Fife KH, Tyring SK, Herne K, Douglas JM (1997a) Acceptability of genital herpes immunization. The role of health beliefs and health behaviors. Sex Transm Dis 24:555-560.
Zimet GD, Liau A, Fortenberry VD (1997b) Health beliefs and intention to get immunized for HIV. J Adolesc Health 20:354-359.
Zmuda JM, Cauley JA, Ferrell RE (1999) Recent progress in understanding the genetic susceptibility to osteoporosis. Genet Epidemiol 16:356-367.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paglierani, L.M., Kalkwarf, H.J., Rosenthal, S.L. et al. The Impact of Test Outcome Certainty on Interest in Genetic Testing Among College Women. Journal of Genetic Counseling 12, 131–150 (2003). https://doi.org/10.1023/A:1022607223097
Issue Date:
DOI: https://doi.org/10.1023/A:1022607223097